| Top 50 Most Viewed Posts Last Week |
|---|
|
Today This Week Last Week This Month Last Month
|
1. MJS719: It looks like Leronlimab will compliment (929)  (16) |
| 2. ohm20: It's absolutely an impediment to raising funds (711) (31) |
| 3. ohm20: Interesting mouse study in Glioblastoma. A cheap (658) (24) |
| 4. Katangolo: Love seeing us partnering. Little CYDY is growing (651) (12) |
| 5. Jake2212: Perhaps TAK, not MRK, lies in LL's future. We all (648) (32) |
| 6. My69z: "$5/$7/$10" buyout -- anyone even whisper (627) (16) |
| 7. grow: Every poster, paper, trial readout, and planned (622) (22) |
| 8. Evil Rabbit: That was Hulk / Blue Heel elsewhere. As a (613) (7) |
| 9. chazzledazzle: Reminded me that I’m curious about Chan. “ (546) (2) |
| 10. cardamine: Every party involved in quashing this miracle (530) (6) |
| 11. craigakess: Good post. There is much to be said for rational (529) |
| 12. KenChowder: Yes, and it's odd. Basically if you have CRC you (529) (12) |
| 13. FKAdamF.: Ohm20, once again, you are the voice of reason (527) (10) |
| 14. KenChowder: Pigs get slaughtered too. You can't milk a pig. (527) (15) |
| 15. KenChowder: Paper by Dr. Jay, Dr. Yang, Scott Hansen et al (519) (16) |
| 16. brentie: From MGK... (513) (5) |
| 17. mountaineer: Accepted 22 August 2024, Available online 30 (508) (2) |
| 18. My69z: chazzle, I'm morally speechless. What an (507) (5) |
| 19. My69z: Zika virus mAb's: Blocking the neonatal Fc (503) (1) |
| 20. sean007: Gilead sells Lenacapavir (aka Sunleca in the (502) (3) |
| 21. Enjay: BuildGoodThings posted this on reddit: Leronlimab (500) (16) |
| 22. craigakess: LOL. Nah, I like and respect EvilRbt as a person (497) (1) |
| 23. seemingly-harmless: new york times article on MASH today. trite (492) (1) |
| 24. sean007: The entire debate about COVID-19 and (492) (15) |
| 25. brentie: From stocktwits: A Randomized Placebo-Controlled (489) (12) |
| 26. docj: Interesting that CYDY doesn't spread the word to (484) (6) |
| 27. HHIGambler: 30 days from the week of Sept 9th would be Oct (482) (16) |
| 28. Evil Rabbit: Personally, I don’t care for the guy. And (478) (3) |
| 29. brentie: I know we saw the abstract, but I never saw the (471) (13) |
| 30. mfglola: Interesting connection between two of our (471) (4) |
| 31. Evil Rabbit: As soon as the relationship with the FDA was (467) (13) |
| 32. mountaineer: Someone will have to explain this. Doesn’t (467) (2) |
| 33. ohm20: I'm a little shocked at the massive number of (466) (9) |
| 34. docj: CytoDyn Engages Syneos Health as CRO For Its (465) (20) |
| 35. KenChowder: The word I liked best in the announcement today (463) (22) |
| 36. KenChowder: I suspect they heard back from the FDA and that (459) (7) |
| 37. Boatbuilder: I’m all for getting a good price, but remember, (456) (1) |
| 38. ohm20: That just means that shares that were previously (455) (9) |
| 39. Evil Rabbit: Perhaps now there’s a Covid paper published we (452) (6) |
| 40. biloxiblues: AI say's The TEMPEST trial's results indeed (450) (5) |
| 41. sean007: "These people"...noted as shorts... I question (449) (6) |
| 42. Figgs: I agree, things are progressing forward. Let (448) (12) |
| 43. chazzledazzle: Amazing. Thx. The 2 challenged subjects, got back (448) |
| 44. brentie: Article in the Columbian, nothing too exciting (445) (12) |
| 45. ohm20: Only 1.7 million shares traded. By now even you (445) (4) |
| 46. DJknows: Only thing that'll change these dynamics will be (444) (8) |
| 47. My69z: Clinicaltrials site search: Showing results for: (443) (4) |
| 48. KenChowder: I think MGK's AI presentation is worth listening (442) (13) |
| 49. Jake2212: " Syneos Health has helped to develop or (436) (23) |
| 50. dfwl28: Odds and Ends Your intestinal tract is your (436) (4) |
